Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

To land on the right foot on the Red Planet, European engineers have been dropping a skeleton of the four-legged ExoMars ...

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

While the story of the hairy leg in The Secret Agent might seem too wild to be true, it's actually based in reality.

MELBOURNE, Australia (AP) — Helping her opponent Marina Stakusic leave court in a wheelchair wasn't how Priscilla Hon ...

THE DVLA’S full list of medical conditions that could affect your legal right to drive have been revealed. The Driver and ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...

PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...

Letsile Tebogo stepped on to the track alongside his teammates, bearing the weight of a nation and a continent on his ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...